Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
NNMT inhibition as a therapeutic strategy has been explored in industry pharmaceutical pipelines (including a Pfizer program for non-alcoholic fatty liver disease that was reportedly discontinued in early clinical development), but no NNMT inhibitor has reached regulatory approval to date
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment
Product Overview AOD-9604 is a synthetic peptide studied in controlled laboratory environments focused on peptide-mediated signalling pathways and molecular regulatory systems
Varying intervals of maintenance doses will then follow it
Moreover, B12 is critical for synthesizing neurotransmitters chemical messengers such as dopamine and serotonin that regulate mood and stress response
US$ 20.55
US$ 29.24
US$ 21.36
US$ 25.00
